pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
◐
Sign In
Subscribe
🐶
home
jobs
news
search
Approval · news · pharmadog
← back to Approval
News · Approval
651
stories
May 5, 26
Breast Cancer Experts Preview Abstracts to Watch at the 2026 ESMO Breast Cancer Congress
onclive
May 5, 26
Viridian data lift prospects for thyroid eye disease drug
biopharma dive
May 5, 26
Dr McGregor on Key End Points of the STRIKE Trial of Tivozanib Plus Pembrolizumab in RCC
onclive
May 5, 26
Dr Kuykendall on the Evolving JAK Inhibitor and Transplant Considerations in Myelofibrosis
onclive
May 5, 26
Opinion: The ‘brain drain’ narrative about health professionals misses half of the story
stat
May 4, 26
Opinion: Mifepristone court ruling makes drug development riskier for everyone
stat
May 4, 26
Celcuity strengthens case for ASCO-spotlighted breast cancer drug
biopharma dive
May 4, 26
With $97M, Latus pursues a different kind of Huntington’s gene therapy
biopharma dive
May 4, 26
STAT+: Pharmalittle: We’re reading about an abortion pill controversy, another UCB deal, and more news
stat
May 4, 26
STAT+: Biotech raises $42 million to run Huntington’s disease trial
stat
May 1, 26
Arvinas’ ‘Protac’ breast cancer drug cleared by FDA
biopharma dive
May 1, 26
Summit’s ‘self-inflicted’ stumble; Esperion’s take-private deal
biopharma dive
May 1, 26
FDA approval for Alzheimer's agitation drug; Esperion goes private in $1.1B deal
endpoints
May 1, 26
PFAS is still in some infant formula
stat
Apr 30, 26
Krazati fails confirmatory trial in colorectal cancer, putting approval at risk
endpoints
Apr 30, 26
Trump drops Casey Means as surgeon general nominee, opts for radiologist Nicole Saphier
stat
Apr 30, 26
UniQure, in ‘symbolic’ win, to seek UK approval of Huntington’s gene therapy
biopharma dive
Apr 30, 26
Lilly posts another ‘blowout quarter’ as focus turns to Foundayo launch
biopharma dive
Apr 30, 26
STAT+: Pharmalittle: We’re reading about a Supreme Court hearing on ‘skinny labels,’ AstraZeneca U.K. expansion, and more
stat
Apr 30, 26
Avalyn, in pursuit of better lung drugs, banks $300M in an IPO
biopharma dive
Apr 29, 26
STAT+: Supreme Court justices appear to signal ‘skinny labeling’ can survive
stat
Apr 29, 26
Teva nabs experimental Tourette drug in $700M Emalex buyout
biopharma dive
Apr 29, 26
Chiesi to buy KalVista in $1.9B deal for rare disease drug
biopharma dive
Apr 29, 26
FDA tests out ‘real-time’ clinical trials; AbbVie closes in on a KRAS biotech
biopharma dive
Apr 29, 26
Food safety experts warn of USDA brain drain
stat
Apr 28, 26
STAT+: Supreme Court to hear case about ‘skinny labeling’ and generic access
stat
Apr 28, 26
Incyte claims double Phase 3 win in vitiligo, will file for approval
endpoints
Apr 28, 26
FDA claims Amgen drug data were ‘manipulated’; Erasca slides despite ‘home run’ results
biopharma dive
Apr 28, 26
STAT+: Boehringer’s obesity drug shows 16.6% weight loss; more data needed
stat
Apr 28, 26
FDA claims trial 'manipulation' tainted approval of ChemoCentryx drug
endpoints
← prev
page 21 of 22
next →
